The World Health Organisation (WHO) said it's updating its guidelines on COVID-19 treatment to reflect the trial results of a common steroid in critical COVID-19 cases.
The preliminary results showed that dexamethasone reduced death rates by about one third for critically ill patients.
"This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
The agency said it will "coordinate a meta-analysis to increase our overall understanding of this intervention" and update the guidelines to "reflect how and when the drug should be used in COVID-19".
The drug has been used since the 1960s to reduce inflammation in diseases such as arthritis.
US envoys arrive in Qatar as mediators work to revive Iran talks
Two dead after wildfire guts house in northern Greece
Afghanistan launches airstrikes on IS targets on border with Pakistan
Bangladesh warns of dengue surge as weather aids spread
Fourteen children killed in Pakistan after tutoring centre roof collapses
Supreme Court rejects Trump bid to restrict birthright citizenship
South Africa's anti-migrant protesters march nationwide
Iran and US agree to halt attacks, uncertainty over Doha talks
